Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
UPDATE: To Acquire Sinovac Biotech (Nasnaq: SVA) Sinobioway Consortium Raises Its Purchase Price To $8 Per Share 2017-07-01 02:43
CHINA AID: one of the most authoritative elderly and long-term care events in China 2017-06-30 22:00
CARsgen Therapeutics Joins The Alliance for Regenerative Medicine 2017-06-30 19:57
Zai Lab Secures Series C Financing 2017-06-29 05:00
To Fight Against The Behavior Between Sinovac's Special Committee And Weidong Yin's Consortium And Their Low Price, Sinobioway Consortium Raises Its Purchase Price To $8 Per Share 2017-06-29 02:10
VolitionRx Limited Corrects an Earlier Announcement 2017-06-27 19:30
8th International Breast Densitometry and Cancer Risk Assessment Conference - Breakthrough therapy to reduce mammographic breast density 2017-06-26 21:00
CARsgen Therapeutics Presented at the 2017 BIO International Convention 2017-06-23 12:00
ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market 2017-06-19 23:15
Shineco, Inc. Enters into Strategic Cooperation Agreement to Establish the Institute of Chinese Apocynum Industrial Technology Research 2017-06-09 20:00
The Scripps Research Institute and ShangPharma Innovation Announce Translational Research Collaboration 2017-06-08 23:00
ShangPharma Innovation Names New Executives-In-Residence 2017-06-07 23:00
CARsgen Presents Phase I Results of CAR-GPC3 T HCC Trial at ASCO 2017 Annual Meeting 2017-06-05 14:30
ShangPharma Innovation Appoints Mohamad Moghadam-Tabrizi as Senior Vice President of Business Development 2017-05-24 23:00
Hebron Technology Co., Ltd. Wins Bid for a Project at Leading Pharmaceutical Company in Tianjin 2017-05-24 18:30
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017 2017-05-20 04:30
China Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders 2017-05-20 04:05
Specialised Therapeutics Asia to License Promising Anti-Cancer Compound Lurbinectedin (PM1183) for South East Asia, Australia and New Zealand 2017-05-18 00:23
Adimmune's Quadrivalent Flu Vaccine Approved by TFDA 2017-05-10 17:46
CPHI to Hold First Quarter 2017 Earnings Conference Call On Friday May 12, 2017 at 8:30 a.m. ET 2017-05-08 18:00
1 138 139 140 141 142 159